Effects of free radicals on coronary artery

Medical Principles and Practice

Volumn 12, Issue 1, 2003, Pages 1-9

  Walia, Mandeep ^a   Kwana, Chiu Yin ^a   Grovera, Ashok K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Cardiac disorders; Ischaemia reperfusion; Oxidative stress; Sarcoplasmic reticulum Ca2+ pump; Vascular disease

Indexed keywords

CALCIMYCIN; FREE RADICAL; ION CHANNEL; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ARTERY CONSTRICTION; ARTERY MUSCLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY; CORONARY ARTERY DISEASE; ENDOTHELIUM; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIA; NONHUMAN; PLIABILITY; REPERFUSION; REVIEW; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FREE RADICALS; HUMANS; NA(+)-K(+)-EXCHANGING ATPASE; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 0242586340     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068159     Document Type: Review

References (59)

1. 2+ in porcine coronary artery. Am J Physiol 1996;270:H134-H141.
2. Chilian WM: Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation. Circulation 1991;84:2108-2122.
3. Godfraind T: Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 1993;110:1201-1205.
4. Cushing DJ, Cohen ML: Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J Pharmacol Exp Ther 1992;261:856-862.
5. Grover AK, Fomin VP, Samson SE: Angiotensin II contractions in coronary artery: Nature of receptors and calcium pools. Mol Cell Biochem 1994;135:11-19.
6. 2+ uptake by intracellular stores. Pharmacol Ther 1991;50:191-232.
7. Drexler H, Hornig B: Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999;31:51-60.
8. Becker AE, de Boer OJ, van Der Wal AC: The role of inflammation and infection in coronary artery disease. Annu Rev Med 2001;52:289-297.
9. Halliwell B: Antioxidants and human disease: A general introduction. Nutr Rev 1997;55:S44-S49.
10. Gross GJ, Auchampach JA: Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc Res 1992;26:1011-1016.
11. Liaudet L, Soriano FG, Szabo C: Biology of nitric oxide signaling. Crit Care Med 2000;28:N37-N52.
12. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
13. Bergendi L, Benes L, Durackova Z, Ferencik M: Chemistry, physiology and pathology of free radicals. Life Sci 1999;65:1865-1874.
14. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
15. Sanders SA, Eisenthal R, Harrison R: NADH oxidase activity of human xanthine oxidoreductase: Generation of superoxide anion. Eur J Biochem 1997;245:541-548.
16. Wang P, Zweier JL: Measurement of nitric oxide and peroxynitrite generation in the post-ischemic heart: Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 1996;271:29223-29230.
17. Dreher D, Junod AF: Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J Cell Physiol 1995;162:147-153.
18. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-1148.
19. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OT: Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 1996;271:H1626-H1634.
20. Howard AB, Alexander RW, Nerem RM, Griendling KK, Taylor WR: Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol 1997;272:C421-C427.
21. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK: Tumor necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998;329:653-657.
22. Yokoyama Y, Beckman JS, Beckman TK, Wheat JK, Cash TG, Freeman BA, Parks DA: Circulating xanthine oxidase: Potential mediator of ischemic injury. Am J Physiol 1990;258:G564-G570.
23. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr: Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA 1998;95:9220-9225.
24. Kuppusamy P, Wang P, Zweier JL, Krishna MC, Mitchell JB, Ma L, Trimble CE, Hsia CJ: Electron paramagnetic resonance imaging of rat heart with nitroxide and polynitroxyl-albumin. Biochemistry 1996;35:7051-7057.
25. 2. Life Sci 2000;66:PL291-PL296.
26. Hogg N, Kalyanaraman B: Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1999;1411:378-384.
27. van der Vliet A, Eiserich JP, Kaur H, Cross CE, Halliwell B: Nitrotyrosine as biomarker for reactive nitrogen species. Methods Enzymol 1996;269:175-184.
28. Finkel T: Oxygen radicals and signaling. Curr Opin Cell Biol 1998;10:248-253.
29. Griendling KK, Ushio-Fukai M: Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000;91:21-27.
30. Torrecillas G, Boyano-Adanez MC, Medina J, Parra T, Griera M, Lopez-Ongil S, Arilla E, Rodriguez-Puyol M, Rodriguez-Puyol D: The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 2001;59:104-112.
31. Rhee SG: Redox signaling: Hydrogen peroxide as intracellular messenger. Exp Mol Med 1999;31:53-59.
32. 2 for platelet-derived growth factor signal transduction. Science 1995;270:296-299.
33. Kaneko M, Matsumoto Y, Hayashi H, Kobayashi A, Yamazaki N: Oxygen free radicals and calcium homeostasis in the heart. Mol Cell Biochem 1994;139:91-100.
34. Kwan CY, Beazley JS: Mechanism of inhibition by alloxan of ATP-driven calcium transport by vascular smooth muscle microsomes. J Bioenerg Biomembr 1988;20:517-531.
35. 2+ transport in vascular-muscle microsomal fractions. Biochem J 1988;254:293-296.
36. Kwan CY, Sipos S, Gaspar V: Alloxan inhibits ligand binding to adrenoceptors of vascular smooth muscle microsomes. Biochem J 1990;270:137-140.
37. Newburger JW: Kawasaki disease. Curr Treat Options Cardiovasc Med 2000;2:227-236.
38. Saadeddin SM, Habbab MA, Ferns GA: Markers of inflammation and coronary artery disease. Med Sci Monit 2002;8:RA5-12.
39. Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, Feingold KR, Grunfeld C: Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 2000;20:1536-1542.
40. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation 2000;101:1372-1378.
41. Navalkar S, Parthasarathy S, Santanam N, Khan BV: Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis. J Am Coll Cardiol 2001;37:440-444.
42. Farmer JA, Torre-Amione G: The renin angiotensin system as a risk factor for coronary artery disease. Curr Atheroscler Rep 2001;3:117-124.
43. Libby P: Coronary artery injury and the biology of atherosclerosis: Inflammation, thrombosis, and stabilization. Am J Cardiol 2000;86:3J-8J.
44. Leung YM, Xion Y, Ou YJ, Kwan CY: Perturbation by lysophosphatidylcholine of membrane permeability in cultured vascular smooth muscle and endothelial cells. Life Sci 1998;63:965-973.
45. 2+(SERCA)-pumps: Link to heart beats and calcium waves. Cell Calcium 1999;25:277-290.
46. Grover AK, Samson SE, Fomin VP: Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol 1992;263:H537-H543.
47. Grover AK, Samson SE: Protection of Ca pump of coronary artery against inactivation by superoxide radical. Am J Physiol 1989;256:C666-C673.
48. 2+ pumps of coronary artery. Am J Physiol 1988;255:C297-C303.
49. 2+ pump in pig coronary artery smooth muscle. Am J Physiol 2002;10.1152/ajpcell.00382.2002.
50. 2+ pump. Am J Physiol 1995;269: C546-C553.
51. Elmoselhi AB, Grover AK: Peroxide sensitivity of endothelin responses in coronary artery smooth muscle: ET(A) vs. ET(B) pathways. Mol Cell Biochem 1999;202:47-52.
52. 2+ pump heterogeneity in coronary artery: Free radicals and IP3-sensitive and -insensitive pools. Am J Physiol 1996;271:C1652-C1659.
53. Gill DL, Ghosh TK, Bian J, Short AD, Waldron RT, Rybak SL: Function and organization of the inositol 1,4,5-trisphosphate-sensitive calcium pool. Adv Second Messenger Phosphoprotein Res 1992;26:265-308.
54. Elmoselhi A, Butcher A, Samson SE, Grover AK: Coronary artery contractility, Na(+)-pump and oxygen radicals. Gen Physiol Biophys 1994;13:247-256.
55. Elmoselhi AB, Butcher A, Samson SE, Grover AK: Free radicals uncouple the sodium pump in pig coronary artery. Am J Physiol 1994;266:C720-C728.
56. Harvey WJ, Blostein R: Uncoupling the red cell sodium pump by proteolysis. J Biol Chem 1986;261:1724-1729.
57. 2+ pump isoform SERCA3 is more resistant than SERCA2b to peroxide. Am J Physiol 1997;273:C420-C425.
58. 2+ pump in endothelium: Implications to coronary artery function. Am J Physiol 1997;273:C1250-C1258.
59. Grover AK, Hui J, Samson SE: Catalase activity in coronary artery endothelium protects smooth muscle against peroxide damage. Eur J Pharmacol 2000;387:87-91.